心血管デバイス市場：デバイスタイプ、適応症、エンドユーザー別-2025-2030年の世界予測

心血管デバイス市場は、2023年に536億9,000万米ドルと評価され、2024年には575億5,000万米ドルに達すると予測され、CAGR 7.38％で成長し、2030年には884億米ドルに達すると予測されています。

心血管デバイス市場には、心血管疾患の診断、管理、治療に使用される幅広い医療機器が含まれます。これには、心電図などの診断機器、ステントやペースメーカーなどの治療機器、高血圧などの慢性疾患の追跡に役立つモニタリング機器などが含まれます。心血管デバイスの必要性は、人口の高齢化、座りがちなライフスタイル、糖尿病や肥満の増加によって、心血管疾患の世界の有病率が高まっていることに起因しています。病院、手術センター、在宅医療の現場で使用され、主に心臓専門医や心臓の健康を専門とするヘルスケア専門家によって使用されています。低侵襲処置の採用の増加とスマート医療機器の継続的な技術進歩が主要な成長促進要因となっています。主なビジネスチャンスは、AIを搭載した診断ツールや個別化医療における患者に特化したソリューションの開発にあり、これらは現在進行中のデジタルヘルスケア変革に合致しています。しかし、高コスト、厳しい規制の枠組み、未発達地域でのアクセス不足などの制約が大きな課題となっています。また、医療機器のリコールやコネクテッドデバイスにおけるサイバーセキュリティの脅威といったハードルにも直面しています。イノベーションは、より良い医療連携を促進するために、機器の接続性と電子カルテ（EHR）との統合を強化することに焦点を当てるべきです。探求すべき主要分野としては、疾患の早期発見のための予測分析、埋め込み型機器の生体適合性と電池寿命の改善などが挙げられます。市場の競争は激しく、技術的リーダーシップを維持するためには研究開発への多額の投資が必要です。企業は、製品のイノベーションと拡張性を促進するために、テクノロジー企業との提携を模索すべきです。さらに、医療従事者向けの研修プログラムを通じてアウトリーチを拡大すれば、医療インフラが未整備の市場に重点を置いて、機器の操作性やメンテナンスに関する問題に取り組める可能性があります。

市場力学：急速に進化する心血管デバイス市場の主要市場インサイトを公開

心血管デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の負担増
  • 低侵襲手術への嗜好の高まり
  • 新興国におけるヘルスケア施設の改善と医療サービスの拡大
• 市場抑制要因
  • 厳しい規制政策と製品リコール
• 市場機会
  • 心臓の健康状態を継続的にモニタリングするためのウェアラブル技術の統合
  • 心血管デバイスの生体適合性と材料科学に関する継続的な調査
• 市場の課題
  • 限られた数の償還政策

ポーターのファイブフォース：心血管デバイス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心血管デバイス市場における外部からの影響の把握

外部マクロ環境要因は、心血管デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心血管デバイス市場における競合情勢の把握

心血管デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心血管デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心血管デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心血管デバイス市場における成功への道筋を描く

心血管デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の負担増加
    • 低侵襲手術への関心の高まり
    • 新興経済国におけるヘルスケア施設の改善とヘルスケアサービスの範囲の拡大
  • 抑制要因
    • 厳格な規制政策と製品リコール
  • 機会
    • 心臓の健康を継続的に監視するためのウェアラブル技術の統合
    • 心臓血管機器の生体適合性と材料科学に関する継続的な調査
  • 課題
    • 払い戻しポリシーの数が限られている
• 市場セグメンテーション分析
  • デバイスタイプ：高血圧の診断と管理に不可欠な血圧計の採用が急増
  • エンドユーザー：外来手術センター全体での心血管デバイスの利用の進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心血管デバイス市場デバイスタイプ別

• 診断および監視デバイス
  • 血圧モニター
  • 心臓CTおよびMRIスキャナ
  • 心電図装置
  • ホルターモニター
  • 遠隔心臓モニタリング
  • ストレステストシステム
• 治療および外科用機器
  • 人工心臓
  • 心臓アブレーションカテーテル
  • 冠動脈ガイドワイヤー
  • 心臓モニター
  • 心臓弁
  • 植込み型除細動器
  • ペースメーカー
  • ステント
  • 補助人工心臓

第7章 心血管デバイス市場適応症別

• 不整脈
• 冠動脈疾患
• 心不全
• 末梢動脈疾患

第8章 心血管デバイス市場：エンドユーザー別

• 外来手術センター
• 病院
• 専門クリニック

第9章 南北アメリカの心血管デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心血管デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心血管デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ジョンソン・エンド・ジョンソンがショックウェーブ・メディカルを131億米ドルで買収、心臓血管ケアの提供を強化
  • メドトロニックとカーディアック・デザイン・ラボがインドで革新的な外部ループ・レコーダー技術を発表
  • InfoBionicのMoMe ARCが心臓モニタリングの革命としてFDAの承認を取得
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• ACS Diagnostics
• Alivecor, Inc.
• Asahi Kasei Corporation
• B. Braun SE
• Baxter International Inc.
• Bexen Medical
• Biotronik SE & Co KG
• Boston Scientific Corporation
• BPL Medical Technologies Private Limited
• GE Healthcare
• HeartFlow Holding, Inc.
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.,
• Lepu Medical Technology（Beijing）Co., Ltd.
• LivaNova PLC
• Medtronic PLC
• Microport Scientific Corporation
• Nihon Kohden Corporation
• Qardio, Inc.
• Schiller AG
• Terumo Medical Corporation
• Tricog Health
• Vesalius Cardiovascular Inc.
• Zoll Medical Corporation

LIST OF FIGURES

• FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 55. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 81. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 82. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 86. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 117. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 122. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 127. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 143. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 163. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 171. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 173. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 178. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 183. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 191. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 193. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 197. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 198. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 203. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 218. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 223. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 228. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 229. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 233. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 234. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 238. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 244. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 246. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiovascular Devices Market was valued at USD 53.69 billion in 2023, expected to reach USD 57.55 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 88.40 billion by 2030.

The cardiovascular devices market encompasses the broad spectrum of medical devices used to diagnose, manage, and treat cardiovascular diseases. This includes diagnostic devices like electrocardiograms, therapeutic devices such as stents and pacemakers, and monitoring devices that help in tracking chronic conditions like hypertension. The necessity of cardiovascular devices stems from the growing global prevalence of cardiovascular diseases, driven by aging populations, sedentary lifestyles, and rising incidences of diabetes and obesity. They find application in hospitals, surgical centers, and at-home care settings, primarily used by cardiologists and healthcare professionals specializing in heart health. Increasing adoption of minimally invasive procedures and continuous technological advancements in smart medical devices serve as major growth drivers. Major opportunities lie in the development of AI-powered diagnostic tools and patient-specific solutions in personalized medicine, which align with the ongoing digital healthcare transformation. However, limitations such as high costs, stringent regulatory frameworks, and lack of access in underdeveloped regions pose significant challenges. The market also faces hurdles through medical device recalls and cybersecurity threats in connected devices. Innovation should focus on enhancing device connectivity and integration with electronic health records (EHRs) to promote better care coordination. Key areas to explore include predictive analytics for early disease detection and improvements in biocompatibility and battery life for implantable devices. The nature of the market is highly competitive with substantial investment in R&D necessary to maintain technological leadership. Companies should explore partnerships with technology firms to foster product innovation and scalability. Additionally, expanding outreach through training programs for healthcare providers could potentially tackle issues related to device operability and maintenance, with an emphasis on markets with healthcare infrastructure deficits.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Devices Market

The Cardiovascular Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing burden of cardiovascular diseases
  • Rising preference for minimally invasive procedures
  • Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
• Market Restraints
  • Stringent regulatory policies and product recalls
• Market Opportunities
  • Integration of wearable technology for continuous monitoring of heart health
  • Ongoing research in the biocompatibility and material science of cardiovascular device
• Market Challenges
  • Limited number of reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Devices Market

A detailed market share analysis in the Cardiovascular Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Devices Market

A strategic analysis of the Cardiovascular Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device Type, market is studied across Diagnostic & Monitoring Devices and Therapeutic & Surgical Devices. The Diagnostic & Monitoring Devices is further studied across Blood Pressure Monitors, Cardiac CT & MRI Scanners, Electrocardiogram Devices, Holter Monitors, Remote Cardiac Monitoring, and Stress Test Systems. The Therapeutic & Surgical Devices is further studied across Artificial Hearts, Cardiac Ablation Catheters, Coronary Guidewires, Heart Monitors, Heart Valves, Implantable Cardioverter Defibrillators, Pacemakers, Stents, and Ventricular Assist Devices.
• Based on Indication, market is studied across Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, and Peripheral Arterial Disease.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing burden of cardiovascular diseases
    • 5.1.1.2. Rising preference for minimally invasive procedures
    • 5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory policies and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
    • 5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
  • 5.1.4. Challenges
    • 5.1.4.1. Limited number of reimbursement policies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
  • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiovascular Devices Market, by Device Type

• 6.1. Introduction
• 6.2. Diagnostic & Monitoring Devices
  • 6.2.1. Blood Pressure Monitors
  • 6.2.2. Cardiac CT & MRI Scanners
  • 6.2.3. Electrocardiogram Devices
  • 6.2.4. Holter Monitors
  • 6.2.5. Remote Cardiac Monitoring
  • 6.2.6. Stress Test Systems
• 6.3. Therapeutic & Surgical Devices
  • 6.3.1. Artificial Hearts
  • 6.3.2. Cardiac Ablation Catheters
  • 6.3.3. Coronary Guidewires
  • 6.3.4. Heart Monitors
  • 6.3.5. Heart Valves
  • 6.3.6. Implantable Cardioverter Defibrillators
  • 6.3.7. Pacemakers
  • 6.3.8. Stents
  • 6.3.9. Ventricular Assist Devices

7. Cardiovascular Devices Market, by Indication

• 7.1. Introduction
• 7.2. Cardiac Arrhythmia
• 7.3. Coronary Artery Disease
• 7.4. Heart Failure
• 7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
  • 12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
  • 12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. ACS Diagnostics
• 3. Alivecor, Inc.
• 4. Asahi Kasei Corporation
• 5. B. Braun SE
• 6. Baxter International Inc.
• 7. Bexen Medical
• 8. Biotronik SE & Co KG
• 9. Boston Scientific Corporation
• 10. BPL Medical Technologies Private Limited
• 11. GE Healthcare
• 12. HeartFlow Holding, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. Koninklijke Philips N.V.,
• 15. Lepu Medical Technology(Beijing)Co., Ltd.
• 16. LivaNova PLC
• 17. Medtronic PLC
• 18. Microport Scientific Corporation
• 19. Nihon Kohden Corporation
• 20. Qardio, Inc.
• 21. Schiller AG
• 22. Terumo Medical Corporation
• 23. Tricog Health
• 24. Vesalius Cardiovascular Inc.
• 25. Zoll Medical Corporation